Get startedLog in
    Picture of PhaseBio Pharmaceuticals logo

    PHASQ — PhaseBio Pharmaceuticals News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro Cap
    All News

    Brief: Phasebio Pharmaceuticals Reports Q1 Loss Of 23 Cents Per Share

    Picture of PhaseBio Pharmaceuticals logoPhaseBio Pharmaceuticals
    16/05/2022 11:03
    May 16 (Reuters) - PhaseBio Pharmaceuticals Inc  PHAS.O :
    * PHASEBIO PHARMACEUTICALS REPORTS FIRST QUARTER 2022 FINANCIAL RESULTS AND
RECENT
BUSINESS HIGHLIGHTS
    * QTRLY  LOSS PER SHARE $0.23
    * Q1 EARNINGS PER SHARE VIEW $-0.66 -- REFINITIV IBES DATA

Source text for Eikon:  ID:nBw1lMQt2a 
Further company coverage:  PHAS.O 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on PhaseBio Pharmaceuticals

    See all news